TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 1 | 6 | -8 | -3 | -8 | -31 | -7 |
| P | %wins | 67 | 100 | 33 | 33 | 67 | 0 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/13/17 17:03 | 6/12/17 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Duchemin Jeffrey | MA | DO | CEO | P | 61 | 2.76 | 0 | 22 | 3 | 789 | D | ||||||||||||||
11/3/16 16:12 | 11/3/16 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Duchemin Jeffrey | MA | DO | CEO | P | 36 | 2.42 | 0 | 15 | 3 | 463 | D | -51 | -26 | -20 | -18 | -19 | -11 | -8 | -2 | 4 | 9 | 4 | 35 | 4 | |
12/11/15 16:58 | 12/10/15 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Duchemin Jeffrey | MA | DO | CEO | P | 34 | 3.37 | 0 | 10 | 7 | 160 | D | -30 | -33 | -38 | -29 | 5 | 9 | 3 | -2 | 1 | 8 | -13 | -14 | 9 | -21 |
9/2/15 16:22 | 9/2/15 | HBIO | Harvard Bioscience Inc | DE | Electr | LabEq | Laboratory Analytical Instrum | Duchemin Jeffrey | MA | DO | CEO | P | 9 | 4.41 | 1 | 2 | 1 | 150 | D | 15 | -5 | -23 | -24 | -15 | -4 | -2 | 0 | -2 | 1 | -14 | -30 | -38 | -40 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |